Potassium Chloride NDC 68462-357

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-357Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0357Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-357-01	68462035701	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-357-01)Marketed from Jan 20, 2016
68462-357-05	68462035705	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-357-05)Marketed from Jan 20, 2016
68462-357-90	68462035790	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-357-90)Marketed from Jun 1, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 750 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202868
Marketing start: Jan 20, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 68462-357_b0251572-aa7f-434a-a7ff-33ccbc37dfafSPL ID b0251572-aa7f-434a-a7ff-33ccbc37dfafSPL set ID 5b054142-7372-4641-be27-dca630a97ad9RxCUI 312504UNII 660YQ98I10
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462035701 followed by a unit qualifier and the quantity

Package 68462-0357-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 29, 2016.

Indications (excerpt from the label)

INDICATIONS AND USAGE BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. 1. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202868

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202868
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 750 mg/1	Capsule, Extended releaseOral	BluePoint Laboratories	68001-396
Potassium Chloride	Potassium chloride 750 mg/1	Capsule, Extended releaseOral	Northstar Rx LLC	16714-824